SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.
Nome Químico: 7β-(Hydroxymethyl)-15α,16α-dihydro-3′H-cyclopropa[15,16]-17α-pregna-3,5-diene-21,17-carbolactone (as per EP)
Sinônimo: 7β-Hydroxymethyldiene Drospirenone (EP) ; 7-Hydroxymethyl 3,5(6)-diene drospirenone
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
Sorrisos: C[C@]12C(C=CCC2)=C[C@H](CO)[C@]3([H])[C@]1([H])CC[C@@]4(C)[C@@]3([H])[C@]([H])(C5)[C@@]5([H])[C@]46OC(CC6)=O
Drospirenone EP Impurity I is chemically 7β-(Hydroxymethyl)-15α,16α-dihydro-3′H-cyclopropa[15,16]-17α-pregna-3,5-diene-21,17-carbolactone (as per EP). It is also known as 7β-Hydroxymethyldiene Drospirenone (EP) ; 7-Hydroxymethyl 3,5(6)-diene drospirenone. Drospirenone EP Impurity I is supplied with detailed characterization data compliant with regulatory guideline. Drospirenone EP Impurity I can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Drospirenone.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Development and validation of new analytical method for simultaneous estimation of drospirenone and ethinyl estradiol
By Karajgi, S. R.; Mallikarjun, D. T.; Somashekhar, M.; Shivakumar, B.
From International Journal of ChemTech Research (2019), 12(5), 108-117
A simple and rapid validated stability indicating HPLC method for the determination of drospirenone in a pharmaceutical product
By Talath, Sirajunisa; Dhaneshwar, Sunil
From Indo American Journal of Pharmaceutical Research (2017), 7(1), 7401-7410